Tolterodine extended release improves overactive bladder symptoms in men with overactive bladder and nocturia
- 31 August 2006
- Vol. 68 (2) , 328-332
- https://doi.org/10.1016/j.urology.2006.03.006
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Safety and Tolerability of Tolterodine for the Treatment of Overactive Bladder in Men With Bladder Outlet ObstructionJournal of Urology, 2006
- TOLTERODINE EXTENDED RELEASE ATTENUATES LOWER URINARY TRACT SYMPTOMS IN MEN WITH BENIGN PROSTATIC HYPERPLASIAJournal of Urology, 2005
- A VALIDATED PATIENT REPORTED MEASURE OF URINARY URGENCY SEVERITY IN OVERACTIVE BLADDER FOR USE IN CLINICAL TRIALSJournal of Urology, 2005
- Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladderBJU International, 2004
- The wet patient: understanding patients with overactive bladder and incontinenceCurrent Medical Research and Opinion, 2004
- Clinical efficacy and tolerability of extended‐release tolterodine and immediate‐release oxybutynin in Japanese and Korean patients with an overactive bladder: a randomized, placebo‐controlled trialBJU International, 2003
- Combination Treatment With an α-Blocker Plus an Anticholinergic for Bladder Outlet Obstruction: A Prospective, Randomized, Controlled StudyJournal of Urology, 2003
- The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence SocietyNeurourology and Urodynamics, 2002
- Evidence for the efficacy and safety of tolterodine in the treatment of overactive bladderExpert Opinion on Pharmacotherapy, 2001
- THE EFFECT OF BLADDER OUTFLOW OBSTRUCTION ON DETRUSOR BLOOD FLOW CHANGES DURING THE VOIDING CYCLE IN CONSCIOUS PIGSJournal of Urology, 2001